ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2136

Arthritogenic Cells Found in the Peripheral Blood of Rheumatoid Arthritis Patients Transfer the Disease to NSG-DR4 Mice

Janine Rupp1, Johannes Fessler2, Silvia Hayer3, Barbara Dreo4, Angelika Lackner2, Patrizia Fasching2, Wolfgang Helmberg2, Peter Schlenke2, Jens Thiel5, Guenter Steiner6, Cornelia M. Weyand7 and Martin Stradner2, 1Medical University Graz, Rochester, MN, 2Medical University of Graz, Graz, Austria, 3Medical University of VIenna, Vienna, Austria, 4Division of Rheumatology and Immunology, Medical University of Graz, Graz, Austria, 5University Hospital Freiburg, Freiburg, Germany, 6Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria, 7Mayo Clinic School of Medicine and Stanford University, Rochester, MN

Meeting: ACR Convergence 2023

Keywords: Mouse Models, RA, rheumatoid arthritis, T Cell

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (2095–2140) RA – Diagnosis, Manifestations, and Outcomes Poster III

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: T cells play an important role in the genesis of rheumatoid arthritis (RA). HLA class II genes, such as HLA-DRB1*0401 (HLA-DR4), confer the strongest genetic risk and suggest involvement of CD4+ T cells. However, the exact pathogenesis of RA is still elusive. Existing mouse models mimic specific aspects of the disease but do not fully recapitulate the human immune system. Thereby current research is limited and would profit from a humanized mouse model. We aimed to identify arthritogenic cells by transferring HLA-DR4+ peripheral blood mononuclear cells (PBMC) of RA patients into NSG-DR4 mice. Thereby generating a novel mouse model with inflammatory joint disease, only triggered by the transfer of human immune cells.

Methods: Humanized NSG-DR4 mice (NSG-AB0 Tg(HLA-DR4)) were generated by injecting PBMC of HLA-DR4 positive patients or controls. Engraftment within peripheral blood, bone marrow, skin, liver, and spleen was assessed comprehensively using multicolor flow cytometry. Development of RA was monitored by examination of the joints, followed by micro computed tomography analysis and histology. Joints were analyzed regarding pannus formation, bone erosions, cartilage damage, and human cell infiltration.

Results: Here, we show that DR4+ T cells of the peripheral blood of RA patients are capable of inducing an RA-like disease in NSG-DR4 mice. These mice recapitulate different hallmarks of the disease including immune cell infiltration, pannus formation, increased osteoclastogenesis, cartilage damage, and bone erosions. Compared to healthy controls, cells of RA patients are more likely to develop inflammatory joint disease in these mice (RA donor 70% vs. healthy control 20%, p=0.00196). T-helper 1 (Th1) cells, dominated the human immune cell composition in humice, while regulatory T cells (Tregs) were diminished compared to donor PBMC composition. Transfer of in vitro Th1 polarized T cells increased arthritis incidence.

Conclusion: Arthritogenic cells found in the peripheral blood of RA patients are capable of inducing an RA-like disease in NSG-DR4 mice. This novel mouse model will allow to identify these cells on a patient-personalized level.


Disclosures: J. Rupp: None; J. Fessler: None; S. Hayer: None; B. Dreo: None; A. Lackner: None; P. Fasching: None; W. Helmberg: None; P. Schlenke: None; J. Thiel: None; G. Steiner: None; C. Weyand: None; M. Stradner: None.

To cite this abstract in AMA style:

Rupp J, Fessler J, Hayer S, Dreo B, Lackner A, Fasching P, Helmberg W, Schlenke P, Thiel J, Steiner G, Weyand C, Stradner M. Arthritogenic Cells Found in the Peripheral Blood of Rheumatoid Arthritis Patients Transfer the Disease to NSG-DR4 Mice [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/arthritogenic-cells-found-in-the-peripheral-blood-of-rheumatoid-arthritis-patients-transfer-the-disease-to-nsg-dr4-mice/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/arthritogenic-cells-found-in-the-peripheral-blood-of-rheumatoid-arthritis-patients-transfer-the-disease-to-nsg-dr4-mice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology